ArticleCureus2024
Risk Factors for Cervical Hematoma After Thyroid Surgery at a Portuguese Hospital: A Retrospective Study.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveCervical hematoma post thyroid surgery is an uncommon but potentially life-threatening postoperative complication. Moreover, despite its low incidence, this complication has been a barrier to outpatient surgical care. Assessing postoperative complication rates and their risk factors can improve the safety and cost-effectiveness of these procedures, which is especially useful in promoting outpatient surgical care. METHODOLOGY: This retrospective study included 198 patients who underwent thyroid surgery in the district of Viseu (Portugal) between January 2020 and December 2021. The sample was analyzed to determine the incidence of cervical hematoma post thyroid surgery and to identify possible medical and modifiable anesthetic risk factors related to hematoma. To determine the risk factors, the sample was divided into two groups: Group 1 included patients without postoperative cervical hematoma and Group 2 included patients with postoperative cervical hematoma Result: The incidence of postoperative cervical hematoma was 6.0%, slightly higher than previously reported in the literature. Univariate analysis identified two factors associated with post-surgical cervical hematoma in our sample: a medical history of obstructive lung disease and intraoperative administration of ketorolac. Several studies have reliably associated a history of chronic obstructive pulmonary disease (COPD) with airway reactivity, especially during an anesthetic emergency. The use of non-steroidal analgesics is widespread in intraoperative practice, and the literature consistently supports the safety of their administration in endocrine cervical surgical procedures. Our study revealed controversies related to this topic, and in our opinion, patients who received intraoperative ketorolac in our cohort tended to follow an opioid-free analgesia regimen, leading to more pain and discomfort post surgery. Discomfort and pain in the immediate postoperative period have been identified as potential risk factors for cervical hematoma.
conclusionPatients with obstructive lung disease should be carefully monitored after thyroid surgery and may not be suitable for an ambulatory thyroidectomy. The risk of postoperative bleeding and the benefits of intraoperative ketorolac administration should be balanced, particularly for high-risk patients like those with obstructive pulmonary disease. The establishment of standardized anesthetic protocols for thyroid surgery can enhance the safety and cost-effectiveness of procedures, helping to define feasible preoperative criteria for patient selection in outpatient care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.